Pharmaceuticals & Biotech Healthcare Sector

OmniAb

Market Cap: US$162.7m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

Esperion Therapeutics

Market Cap: US$162.5m

A pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.

Prime Medicine

Market Cap: US$162.3m

A biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States.

Anteris Technologies Global

Market Cap: AU$250.6m

A structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases.

AVITA Medical

Market Cap: US$160.5m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

LENSAR

Market Cap: US$160.1m

A commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System.

Anika Therapeutics

Market Cap: US$159.8m

A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.

Tiziana Life Sciences

Market Cap: US$159.4m

A biotechnology company, specializes in the development of transformative therapies for neurodegenerative and lung diseases in the United States.

Profound Medical

Market Cap: CA$220.3m

Operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland.

4D Molecular Therapeutics

Market Cap: US$158.4m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

Instil Bio

Market Cap: US$158.0m

A clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies.

Diaceutics

Market Cap: UK£116.2m

A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharma and biotech companies.

EKF Diagnostics Holdings

Market Cap: UK£116.0m

Engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally.

Voyager Therapeutics

Market Cap: US$156.0m

A biotechnology company, focuses on the human genetics for the cure of neurological diseases.

Lineage Cell Therapeutics

Market Cap: US$155.9m

A clinical-stage biotechnology company, develops novel cell therapies for neurological and ophthalmic conditions in the United States and internationally.

Race Oncology

Market Cap: AU$241.5m

A clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments.

BioSig Technologies

Market Cap: US$155.5m

A medical technology company, provides digital signal processing technology platform services in the United States.

Joint

Market Cap: US$154.6m

Operates and franchises chiropractic clinics in the United States.

Wellgistics Health

Market Cap: US$154.0m

Engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States.

Rapid Micro Biosystems

Market Cap: US$153.5m

A life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally.

Longduoduo

Market Cap: US$149.8m

Together its subsidiaries, provides preventive healthcare solutions in the People’s Republic of China.

Exagen

Market Cap: US$148.8m

Designs, develops, and commercializes various testing products under the AVISE brand in the United States.

Cogstate

Market Cap: AU$227.9m

A neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research.

hVIVO

Market Cap: UK£108.9m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

Pro-Dex

Market Cap: US$143.8m

Designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide.

Vireo Growth

Market Cap: CA$198.3m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.

BioAge Labs

Market Cap: US$141.6m

A biopharmaceutical company that develops therapeutic product candidates for metabolic diseases.

Alpha Cognition

Market Cap: US$141.3m

A biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada.

NeOnc Technologies Holdings

Market Cap: US$141.0m

A clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies.

Fate Therapeutics

Market Cap: US$139.9m

A clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally.

TerrAscend

Market Cap: CA$192.5m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

ALT5 Sigma

Market Cap: US$138.1m

Provides blockchain-powered technologies worldwide.

Editas Medicine

Market Cap: US$138.1m

A clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases.

DocGo

Market Cap: US$137.8m

Provides mobile health and medical transportation services in the United States and the United Kingdom.

Eupraxia Pharmaceuticals

Market Cap: CA$190.4m

A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.

Aclaris Therapeutics

Market Cap: US$137.5m

A clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States.